These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8442292)
1. Reduction in primary nonfunction of pancreas islet transplants with antithymocyte globulin agents, deoxyspergualin, and splenectomy. Pittman K; Thomas F; McFadden T; Haisch C; Thomas J Transplant Proc; 1993 Feb; 25(1 Pt 2):986-7. PubMed ID: 8442292 [TBL] [Abstract][Full Text] [Related]
2. Deoxyspergualin and rabbit antithymocyte globulin markedly prolong discordant pig pancreatic islet xenografts. Henretta J; Pittman K; McFadden T; Thomas J; Thomas F Transplant Proc; 1993 Feb; 25(1 Pt 1):412-3. PubMed ID: 8438358 [No Abstract] [Full Text] [Related]
3. Reduction of primary nonfunction in discordant pancreas islet xenografts. Pittman K; Thomas J; Thomas F Transplant Proc; 1992 Apr; 24(2):649-50. PubMed ID: 1566465 [No Abstract] [Full Text] [Related]
4. Deoxyspergualin is a unique immunosuppressive agent with selective utility in inducing tolerance to pancreas islet xenografts. Thomas F; Pittman K; Ljung T; Cekada E Transplant Proc; 1995 Feb; 27(1):417-9. PubMed ID: 7879045 [TBL] [Abstract][Full Text] [Related]
5. Long-term (10-month) pig islet xenograft tolerance using measured total lymphoid irradiation, splenectomy, short-term rabbit antithymocyte globulin, and deoxyspergualin without long-term immunosuppression. Llyung T; Contreras J; Thomas F; Pittman K; Thomas J Transplant Proc; 1999; 31(1-2):962-3. PubMed ID: 10083428 [No Abstract] [Full Text] [Related]
6. Six- to eight-month survival of discordant pig islet xenografts documented by differential species, insulin, and C-peptide in animals given short-term immunosuppression. Henretta J; McFadden T; Pittman K; Thomas J; Thomas F Transplant Proc; 1994 Jun; 26(3):1138-9. PubMed ID: 8029861 [No Abstract] [Full Text] [Related]
7. Successful discordant pancreatic islet xenotransplantation by prevention of primary nonfunction graft rejection and autoimmune disease recurrence. Henretta J; Pittman K; McFadden T; Thomas F Transplant Proc; 1994 Jun; 26(3):1133-4. PubMed ID: 8029859 [No Abstract] [Full Text] [Related]
8. Prevention of primary nonfunction of xenograft islets. Pittman K; Henretta J; McFadden T; Thomas J; Thomas FT Transplant Proc; 1994 Jun; 26(3):1141-2. PubMed ID: 8029862 [No Abstract] [Full Text] [Related]
9. Reversal of type II diabetes by pancreas islet transplant in four separate animal models of type II diabetes. Thomas F; Pittman K; McFadden T; Haisch C; Peterson R; Thomas J Transplant Proc; 1993 Feb; 25(1 Pt 2):992-3. PubMed ID: 8442295 [No Abstract] [Full Text] [Related]
10. Use of discordant islet xenografts for the treatment of type II diabetes. Pittman K; Henretta J; Thomas J; Thomas F Transplant Proc; 1994 Jun; 26(3):1135-7. PubMed ID: 8029860 [No Abstract] [Full Text] [Related]